Drug Profile
FKK 01PD
Alternative Names: Apomorphine prodrug - Fabre-Kramer Pharmaceuticals; FKK-01PD; TGHW 01APLatest Information Update: 30 Nov 2023
Price :
$50
*
At a glance
- Originator Fabre-Kramer Pharmaceuticals
- Class Antiparkinsonians; Erectile dysfunction therapies
- Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Erectile dysfunction; Parkinson's disease
Most Recent Events
- 30 Nov 2023 FKK 01PD is still in preclinical development for Parkinson’s disease and Erectile Dysfunction in USA (Fabre-Kramer Pharmaceuticals pipeline, November 2023)
- 15 Jun 2021 FKK 01PD is still in preclinical trials for Erectile-dysfunction and Parkinson's-disease in USA (PO, Capsule) (Fabre-Kramer Pharmaceuticals pipeline, June 2021)
- 18 Jan 2017 Preclinical development is ongoing for Parkinson's disease and Erectile dysfunction in USA (Fabre Kramer website, January 2017)